Valeris delivers end-to-end life sciences commercialization support for biopharmaceuticals, spanning strategy, patient access, and provider engagement. Its platform combines patient access and affordability programs, payer reimbursement support, data insights, and clinician engagement tools to streamline the patient journey. By integrating PharmaCord’s patient services with Mercalis’s technology and market access infrastructure, Valeris positions itself as an independent, scalable partner in patient access and support. Backed by Permira and Odyssey Investment Partners, Valeris helps clients navigate market access, speed therapy adoption, improve patient outcomes, and generate actionable commercialization insights.
Company Size
201-500
Company Stage
N/A
Total Funding
N/A
Headquarters
N/A
Founded
N/A
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?